22.05.2017 Views

Review of Pharmacology - 9E (2015)

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cardiovascular System<br />

depolarized cells with fast response action potential. They either do not change or decrease<br />

the APD in non-depolarized tissues. These drugs are used only for ventricular arrhythmia.<br />

• Lignocaine is the most commonly used local anaesthetic agent. It has very high<br />

first pass metabolism, therefore administered only by i.v. route. Excessive dose<br />

can lead to neurological toxicity (drowsiness, paraesthesia, convulsions and coma)<br />

and myocardial depression. It is the drug <strong>of</strong> choice for the treatment <strong>of</strong> ventricular<br />

arrhythmias due to digitalis toxicity. (ineffective in atrial arrhythmias).<br />

• Mexiletine is an orally active lignocaine derivative with all the properties <strong>of</strong><br />

lignocaine.<br />

• Phenytoin is a popular antiepileptic drug. It can be used as an alternative to<br />

lignocaine for digitalis induced ventricular arrhythmias.<br />

• Tocainide (group Ib drug having similar name as group Ic drugs like encainide<br />

and flecainide) can be given orally but not used widely because <strong>of</strong> risk <strong>of</strong><br />

agranulocytosis.<br />

Lignocaine is drug <strong>of</strong> choice<br />

for digitals-induced ventricular<br />

arrhythmias<br />

Procainamide is metabolized in<br />

liver by acetylation<br />

Treatment <strong>of</strong> choice for WPW<br />

syndrome is radi<strong>of</strong>requency<br />

ablation <strong>of</strong> the aberrant pathway<br />

CLASS IC AGENTS<br />

These agents have the most potent sodium channel blocking effects with negligible effect on<br />

K + channels (therefore no effect on APD). These have slow kinetics (τ > 10s). Drugs in this<br />

group include encainide, moricizine, flecainide and propafenone. These drugs have maximum proarrhythmic<br />

property, therefore indicated only for the resistant and life-threatening ventricular<br />

tachycardia or ventricular fibrillation and for the treatment <strong>of</strong> refractory supraventricular<br />

tachycardia. Flecainide can be used for acute treatment <strong>of</strong> Wolff Parkinson White (WPW)<br />

syndrome. [Treatment <strong>of</strong> choice for WPW syndrome is radi<strong>of</strong>requency ablation <strong>of</strong> the aberrant<br />

pathway].<br />

Class II Agents<br />

Class II agents are conventional beta blockers. They act by blocking the effects <strong>of</strong> adrenaline<br />

and nor-adrenaline at the β 1<br />

receptors, thereby decreasing the sympathetic activity on the<br />

heart. These agents are particularly useful in the treatment <strong>of</strong> supraventricular tachycardia.<br />

These drugs decrease the slope <strong>of</strong> phase 4 (responsible for automaticity) and conduction through<br />

the AV node. Important β blockers used as antiarrhythmic agents are esmolol, propranolol, and<br />

metoprolol. Esmolol is the shortest acting beta blocker. It can be used i.v. for the emergency<br />

control <strong>of</strong> ventricular rate in atrial fibrillation or flutter.<br />

General Cardiovascular <strong>Pharmacology</strong> System<br />

Class III Agents<br />

Class III agents predominantly block the potassium channels, thereby prolonging repolarization<br />

(prolongation <strong>of</strong> APD). These drugs may precipitate torsades de’pointes due to prolongation <strong>of</strong><br />

QT interval.<br />

Fig. 5.7: Action <strong>of</strong> class III antiarrhythmic<br />

agents (shown by<br />

dotted line)<br />

These drugs exhibit reverse use dependent prolongation <strong>of</strong> the action potential duration (Reverse<br />

use-dependence). This means that the refractoriness increases at lower heart rates, therefore<br />

169<br />

https://kat.cr/user/Blink99/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!